Companies/TW/4157

TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED

Ownership & governance

Executives 5Directors 9Avg age 76Avg tenure 12.3y
Philip Huang
Chief Executive Officer
Since 2019-01-01Profile →

Executives5

Philip Huang
Chief Executive Officer
Since 2019-01-01
Richard Lue
Director of Finance/CFO
Since 2016-03-31
Hsuan Ju Wang
Investor Relations Contact
—
MIng Tsung Kao
Comptroller/Controller/Auditor
Since 2019-12-15
Chu Chung Lin
Corporate Officer/Principal
—

Board of directors9

Shou-Chuan Ho
Director/Board Member
—Since 2013-04-28
Hong Jen Chang
Director/Board Member
Age 70Since 2013-03-31
Sheng Fu Yu
Director/Board Member
Age 81Since 2019-06-11
Weng Hung Huang
Director/Board Member
—Since 2011-06-23
Kuo-Hsi Wang
Director/Board Member
—Since 2009-03-02
Ming-Chu Hsu
Chairman
—Since 2001-03-31
Philip Huang
Chairman
—Since 2019-01-01
Yen Hua Huang
Director/Board Member
—Since 2007-12-30

Catalog · 2026-07-09

Registry officers14

NameRoleSinceShares
Ming-Chu HsuChairman2001-03-31-
Philip HuangChairman2019-01-01-
Philip HuangChief Executive Officer2019-01-01-
Richard LueDirector of Finance/CFO2016-03-31-
Hong Jen ChangDirector/Board Member2013-03-31-
Kuo-Hsi WangDirector/Board Member2009-03-02-
Sheng Fu YuDirector/Board Member2019-06-11-
Shou-Chuan HoDirector/Board Member2013-04-28-

Registry · as of 2026-07-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus none

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers